Contract 75A50124C00053
Ad Astra Diagnostics, Inc. · Department Of Health And Human Services · September 19, 2024
Ad Astra Diagnostics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 19, 2024 for $6.70 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Morrisville, NC. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 13, 2026. If all options are exercised, the contract could reach $14.31 million.
Contract details
- PIID
- 75A50124C00053
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Morrisville, NC
- First action
- September 19, 2024
- Latest action
- April 13, 2026
Description
AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION SEVERITY AND SOLVING SEPSIS
Modification timeline
-
April 13, 2026Mod P00005AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION$0
-
February 13, 2026Mod P00004AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION$1.70M
-
August 28, 2025Mod P00003AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION$0
-
May 30, 2025Mod P00002AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION$0
-
March 12, 2025Mod P00001AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION$0
-
September 19, 2024Base awardAD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION$5.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00053?
Contract 75A50124C00053 is a federal contract awarded to Ad Astra Diagnostics, Inc. by Department Of Health And Human Services on September 19, 2024 for $6.70 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 5 times since the base award.
Who won contract 75A50124C00053?
Ad Astra Diagnostics, Inc. won contract 75A50124C00053 from Department Of Health And Human Services.
How much is contract 75A50124C00053 worth?
Contract 75A50124C00053 has obligated $6.70 million to date, with a total potential value of $14.31 million if all options are exercised.